Global Apheresis Market was valued at US$ 3,248.3 million in 2023 and is projected to attain a valuation of US$ 6,882.1 million by 2032 at a CAGR of 8.7% during the forecast period 2024–2032. A ...

Q4 2024 Management View CEO Mark Newcomer highlighted that Paysign achieved exceptional growth in its patient affordability business in 2024, with annual revenue increasing by 212% to $12.7 million.

Autoimmune diseases make the immune system attack healthy tissues. These can affect organs like kidneys, leading to ...

Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due to market skepticism. Risks include the ex-US trial locations for GBS and ...

Dr Saroj Ghaskadbi, 65, has never felt a stronger bond with her husband Dr Surendra Ghaskadbi, who donated his kidney to her ...